Last Updated: November 14, 2026

List of Supplementary Protection Certificates

« Back to Dashboard

Supplementary Protection Certificates

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Country	Patent Number	Supplementary Protection Certificate	SPC Country	SPC Description	SPC Expiration
European Patent Office	2343304	132020000000082	Italy	PRODUCT NAME: CRISABOROLO, OPZIONALMENTE NELLA FORMA DI UN SALE FARMACEUTICAMENTE ACCETTABILE(STAQUIS); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/19/1421, 20200401	⤷ Start Trial
European Patent Office	1988877	C201430051	Spain	PRODUCT NAME: INGENOL MEBUTATO O UN DERIVADO ESTER DEL MISMO.; NATIONAL AUTHORISATION NUMBER: EU/1/12/796; DATE OF AUTHORISATION: 20121115; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/12/796; DATE OF FIRST AUTHORISATION IN EEA: 20121115	⤷ Start Trial
European Patent Office	2435432	C20170017 00231	Estonia	PRODUCT NAME: VENETOKLAKS;REG NO/DATE: EU/1/16/1138 07.12.2016	⤷ Start Trial
European Patent Office	4095130	CR 2024 00027	Denmark	PRODUCT NAME: LUTETIUM (177LU) VIPIVOTIDETETRAXETAN; REG. NO/DATE: EU/1/22/1703 20221212	⤷ Start Trial
European Patent Office	2368550	C20190027 00294	Estonia	PRODUCT NAME: APALUTAMIID;REG NO/DATE: EU/1/18/1342 16.01.2019	⤷ Start Trial
European Patent Office	2326621	2490310-6	Sweden	PRODUCT NAME: ETRASIMOD, ELLER ETT FARMACEUTISKT ACCEPTABELT SALT DAERAV, SASOM ETRASIMODARGININ; REG. NO/DATE: EU/1/23/1790 20240219	⤷ Start Trial
>Country	>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Description	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.